01.09.2017
- AstraZeneca and Takeda have agreed to jointly develop and commercialize a potential treatment for Parkinson’s disease. The companies will collaborate to advance MEDI1341, an...
24.11.2016
- Irish drugmaker Allergan has beefed up its pipeline for neurodegenerative disorders with the acquisition of US-based Chase Pharmaceuticals. Under the terms of the deal, Allergan...
